STOCK TITAN

Cutera Stock Price, News & Analysis

CUTR NASDAQ

Company Description

Overview of Cutera Inc

Cutera Inc is a pioneering company in laser technology and medical aesthetics that designs, develops, manufactures, markets, and services a comprehensive range of energy-based medical aesthetic systems. Renowned for its advanced ND:YAG technology, Cutera offers safe and effective treatment solutions that are used by medical professionals globally to address a variety of aesthetic concerns including skin resurfacing, acne treatment, body contouring, and hair removal. The company has earned a reputation as a trusted authority in the aesthetic device industry by consistently delivering state-of-the-art products that integrate innovation, sophistication, and performance.

Innovative Technology and Product Portfolio

Cutera's success is built upon its commitment to advancing laser and optical engineering. At its core, the company develops high-performance devices that harness energy to produce precise outcomes for various medical aesthetic procedures. Its portfolio includes a collection of premium products designed around the needs of the medical aesthetic community, enabling clinicians to deliver faster and safer procedures. With a focus on energy-based modalities, Cutera champions breakthrough technologies that combine picosecond, nanosecond, and dual-wavelength systems to enhance safety and efficacy in treatments.

Business Model and Market Presence

The company primarily derives its revenue through the direct sale and servicing of its innovative devices, backed by a strong network of operations in North America and multiple key international markets. Cutera maintains a significant market presence by continually updating its product offerings to match evolving clinical needs, and by keeping its focus on regulatory compliance and performance excellence. Its operations are built on a model that emphasizes customer support, ongoing clinical education, and product reliability, ensuring practitioners can trust the devices’ performance on a global scale.

Operational Excellence and Industry Position

Cutera sets itself apart by not only offering cutting-edge technology but also instilling confidence in practitioners through balanced design and effective usability. The company focuses on developing solutions that ensure better results through carefully designed energy-based systems. This process is supported by a deep understanding of anatomical nuances and treatment protocols, making its products highly adaptable across various clinical applications. Such operational excellence positions Cutera as an integral player in the medical aesthetics landscape, where it continues to meet the sophisticated demands of both clinicians and patients.

Commitment to Safety and Efficacy

Safety and efficacy remain central to the design of Cutera's devices, which are engineered to deliver predictable outcomes while minimizing risks. The company adheres to strict quality standards and regulatory guidelines, ensuring that every system functions reliably across diverse clinical scenarios. This focus on patient safety and treatment effectiveness is fundamental to its reputation and long-standing trust among practitioners globally.

Comprehensive Support and Market Adaptation

Understanding that innovation alone does not define success, Cutera also invests in comprehensive support systems, ensuring that medical professionals receive continuous training and technical assistance. This approach helps maximize the performance of their devices in clinical settings, thereby reinforcing their commitment to ongoing product development and customer-centric solutions. The company's ability to adapt its product strategies in response to market feedback underlines its expertise and dedication to meeting the evolving needs of the medical aesthetics industry.

Global Influence and Industry Expertise

With direct operations in numerous countries, Cutera leverages its global footprint to steer advancements in the energy-based aesthetics arena. Its international presence not only broadens its market reach but also enhances its capacity for cross-border innovation, enriching the experience and expertise shared within the medical aesthetics community. In doing so, the company provides valuable insights into best practices, industry trends, and technological progress, fostering a collaborative environment that benefits practitioners and patients alike.

Stock Performance

$—
0.00%
0.00
Last updated:
-95.2 %
Performance 1 year
$8.6M
Market Cap
20.2M
Shares outstanding

SEC Filings

No SEC filings available for Cutera.

Financial Highlights

$32,500,000
Revenue (TTM)
-$39,018,000
Net Income (TTM)
-$1.94
Diluted EPS (TTM)
-$24,742,000
Operating Cash Flow
-120.06%
Net Profit Margin
-111.44%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Cutera (CUTR)?

The current stock price of Cutera (CUTR) is $0.0969 as of April 29, 2025.

What is the market cap of Cutera (CUTR)?

The market cap of Cutera (CUTR) is approximately 8.6M.

What is the revenue (TTM) of Cutera (CUTR) stock?

The trailing twelve months (TTM) revenue of Cutera (CUTR) is $32,500,000.

What is the net income of Cutera (CUTR)?

The trailing twelve months (TTM) net income of Cutera (CUTR) is -$39,018,000.

What is the earnings per share (EPS) of Cutera (CUTR)?

The diluted earnings per share (EPS) of Cutera (CUTR) is -$1.94 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Cutera (CUTR)?

The operating cash flow of Cutera (CUTR) is -$24,742,000.

What is the profit margin of Cutera (CUTR)?

The net profit margin of Cutera (CUTR) is -120.06%.

What is the operating margin of Cutera (CUTR)?

The operating profit margin of Cutera (CUTR) is -111.44%.

What is the gross margin of Cutera (CUTR)?

The gross profit margin of Cutera (CUTR) is 5.58%.

What is the current ratio of Cutera (CUTR)?

The current ratio of Cutera (CUTR) is 2.88, indicating the company's ability to pay short-term obligations.

What is the gross profit of Cutera (CUTR)?

The gross profit of Cutera (CUTR) is $1,813,000 on a trailing twelve months (TTM) basis.

What is the operating income of Cutera (CUTR)?

The operating income of Cutera (CUTR) is -$36,217,000.

What is Cutera Inc's core business?

Cutera Inc designs, develops, manufactures, and services energy-based medical aesthetic systems used in procedures such as skin resurfacing, body contouring, and hair removal.

What type of technology does Cutera specialize in?

Cutera is renowned for its advanced laser and optical technologies, including ND:YAG and systems that combine picosecond, nanosecond, and dual-wavelength capabilities for enhanced treatment precision.

How does Cutera generate revenue?

The company generates revenue primarily through the direct sale and servicing of its innovative devices, supported by a robust network of operations in key markets around the globe.

What are the key clinical applications of Cutera's products?

Cutera's devices are used for a variety of medical aesthetic procedures, including acne treatment, body contouring, skin resurfacing, hair removal, and the treatment of benign pigmented lesions and vascular conditions.

How does Cutera ensure patient safety and treatment efficacy?

Safety and efficacy are at the forefront of Cutera's design philosophy. The company adheres to rigorous quality standards and regulatory guidelines to ensure that every device delivers reliable performance in clinical settings.

What distinguishes Cutera from its competitors?

Cutera differentiates itself through its pioneering role in laser technology, its commitment to constant innovation, and its comprehensive support systems that enhance device performance and clinical outcomes.

In which markets does Cutera operate?

Cutera has a strong presence in the United States and operates internationally through direct and allied operations, serving a global network of medical professionals.

How does Cutera support the medical aesthetic community?

The company offers ongoing training, technical support, and product education to ensure that practitioners can maximize device performance and achieve optimal treatment outcomes.